Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2016 (2016), Article ID 4518754, 10 pages
http://dx.doi.org/10.1155/2016/4518754
Research Article

Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARα

1Laboratory of Cardiovascular Internal Medicine Department, First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang 150001, China
2Department of Emergency Surgery, First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang 150001, China

Received 24 December 2015; Revised 17 April 2016; Accepted 24 May 2016

Academic Editor: Nigora Mukhamedova

Copyright © 2016 Jing Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Doenst, T. D. Nguyen, and E. D. Abel, “Cardiac metabolism in heart failure: implications beyond ATP production,” Circulation Research, vol. 113, no. 6, pp. 709–724, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Neubauer, “The failing heart—an engine out of fuel,” The New England Journal of Medicine, vol. 356, no. 11, pp. 1140–1151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Amorim, T. D. Nguyen, Y. Shingu et al., “Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression,” Journal of Thoracic and Cardiovascular Surgery, vol. 140, no. 5, pp. 1160–1167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. C. Heather, M. A. Cole, C. A. Lygate et al., “Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart,” Cardiovascular Research, vol. 72, no. 3, pp. 430–437, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Rosenblatt-Velin, C. Montessuit, I. Papageorgiou, J. Terrand, and R. Lerch, “Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism,” Cardiovascular Research, vol. 52, no. 3, pp. 407–416, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. G. C. Rowe, A. Jiang, and Z. Arany, “PGC-1 coactivators in cardiac development and disease,” Circulation Research, vol. 107, no. 7, pp. 825–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. N. Finck, “The PPAR regulatory system in cardiac physiology and disease,” Cardiovascular Research, vol. 73, no. 2, pp. 269–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Cavasin, Z.-Y. Tao, A.-L. Yu, and X.-P. Yang, “Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 290, no. 5, pp. H2043–H2050, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Cavasin, S. S. Sankey, A.-L. Yu, S. Menon, and X.-P. Yang, “Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 5, pp. H1560–H1569, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Nahrendorf, S. Frantz, K. Hu et al., “Effect of testosterone on post-myocardial infarction remodeling and function,” Cardiovascular Research, vol. 57, no. 2, pp. 370–378, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Pongkan, S. C. Chattipakorn, and N. Chattipakorn, “Chronic testosterone replacement exerts cardioprotection against cardiac ischemia-reperfusion injury by attenuating mitochondrial dysfunction in testosterone-deprived rats,” PLoS ONE, vol. 10, no. 3, article e0122503, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Tsang, S. Wu, J. Liu, and T. M. Wong, “Testosterone protects rat hearts against ischaemic insults by enhancing the effects of α1-adrenoceptor stimulation,” British Journal of Pharmacology, vol. 153, no. 4, pp. 693–709, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. J. Malkin, P. J. Pugh, P. D. Morris, S. Asif, T. H. Jones, and K. S. Channer, “Low serum testosterone and increased mortality in men with coronary heart disease,” Heart, vol. 96, no. 22, pp. 1821–1825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. D. M. Kelly and T. H. Jones, “Testosterone: a metabolic hormone in health and disease,” Journal of Endocrinology, vol. 217, no. 3, pp. R25–R45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Wang, G. Jackson, T. H. Jones et al., “Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes,” Diabetes Care, vol. 34, no. 7, pp. 1669–1675, 2011. View at Google Scholar
  16. R. Haring, U. John, H. Völzke et al., “Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality,” Gender Medicine, vol. 9, no. 6, pp. 557–568, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Wittnich, L. Tan, J. Wallen, and M. Belanger, “Sex differences in myocardial metabolism and cardiac function: an emerging concept,” Pflugers Archiv European Journal of Physiology, vol. 465, no. 5, pp. 719–729, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. K. L. Golden, J. D. Marsh, Y. Jiang, T. Brown, and J. Moulden, “Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes,” American Journal of Physiology—Endocrinology and Metabolism, vol. 285, no. 3, pp. E449–E453, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. K. K. Maddali, D. H. Korzick, D. L. Tharp, and D. K. Bowles, “PKCδ mediates testosterone-induced increases in coronary smooth muscle Cav1.2,” The Journal of Biological Chemistry, vol. 280, no. 52, pp. 43024–43029, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Sun, L. Fu, X. Tang et al., “Testosterone modulation of cardiac β-adrenergic signals in a rat model of heart failure,” General and Comparative Endocrinology, vol. 172, no. 3, pp. 518–525, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Chen, L. Fu, Y. Han et al., “Testosterone replacement therapy promotes angiogenesis after acute myocardial infarction by enhancing expression of cytokines HIF-1a, SDF-1a and VEGF,” European Journal of Pharmacology, vol. 684, no. 1–3, pp. 116–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Liu, J. Geng, Y. Liu et al., “β3-Adrenoceptor mediates metabolic protein remodeling in a rabbit model of tachypacing-induced atrial fibrillation,” Cellular Physiology and Biochemistry, vol. 32, no. 6, pp. 1631–1642, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Han, L. Fu, W. Sun et al., “Neuroprotective effects of testosterone upon cardiac sympathetic function in rats with induced heart failure,” European Journal of Pharmacology, vol. 619, no. 1–3, pp. 68–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Wang, J. Yang, J. Sun et al., “Testosterone replacement attenuates mitochondrial damage in a rat model of myocardial infarction,” Journal of Endocrinology, vol. 225, no. 2, pp. 101–111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Abozguia, G. N. Shivu, I. Ahmed, T. T. Phan, and M. P. Frenneaux, “The heart metabolism: pathophysiological aspects in ischaemia and heart failure,” Current Pharmaceutical Design, vol. 15, no. 8, pp. 827–835, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. P. S. Azevedo, M. F. Minicucci, P. P. Santos, S. A. R. Paiva, and L. A. M. Zornoff, “Energy metabolism in cardiac remodeling and heart failure,” Cardiology in Review, vol. 21, no. 3, pp. 135–140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Van Bilsen, F. A. Van Nieuwenhoven, and G. J. Van Der Vusse, “Metabolic remodelling of the failing heart: beneficial or detrimental?” Cardiovascular Research, vol. 81, no. 3, pp. 420–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. P.-H. Lou, L. Y. Zhang, E. Lucchinetti et al., “Infarct-remodelled hearts with limited oxidative capacity boost fatty acid oxidation after conditioning against ischaemia/reperfusion injury,” Cardiovascular Research, vol. 97, no. 2, pp. 251–261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Tanno and A. Kuno, “Reversal of metabolic shift in post-infarct-remodelled hearts: possible novel therapeutic approach,” Cardiovascular Research, vol. 97, no. 2, pp. 195–196, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. E. M. Burkart, N. Sambandam, X. Han et al., “Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart,” Journal of Clinical Investigation, vol. 117, no. 12, pp. 3930–3939, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. F. M. Campbell, R. Kozak, A. Wagner et al., “A role for peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase,” The Journal of Biological Chemistry, vol. 277, no. 6, pp. 4098–4103, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Panagia, G. F. Gibbons, G. K. Radda, and K. Clarke, “PPAR-α activation required for decreased glucose uptake and increased susceptibility to injury during ischemia,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 288, no. 6, pp. H2677–H2683, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. C. J. Pol, M. Lieu, and K. Drosatos, “PPARs: protectors or opponents of myocardial function?” PPAR Research, vol. 2015, Article ID 835985, 19 pages, 2015. View at Publisher · View at Google Scholar
  34. P. M. Barger, J. M. Brandt, T. C. Leone, C. J. Weinheimer, and D. P. Kelly, “Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth,” The Journal of Clinical Investigation, vol. 105, no. 12, pp. 1723–1730, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Masamura, N. Tanaka, M. Yoshida et al., “Myocardial metabolic regulation through peroxisome proliferator-activated receptor alpha after myocardial infarction,” Experimental and Clinical Cardiology, vol. 8, no. 2, pp. 61–66, 2003. View at Google Scholar · View at Scopus
  36. J. Karbowska, Z. Kochan, and R. T. Smolenski, “Peroxisome proliferator-activated receptor α is downregulated in the failing human heart,” Cellular and Molecular Biology Letters, vol. 8, no. 1, pp. 49–53, 2003. View at Google Scholar · View at Scopus
  37. E. E. Morgan, J. H. Rennison, M. E. Young et al., “Effects of chronic activation of peroxisome proliferator-activated receptor-α or high-fat feeding in a rat infarct model of heart failure,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 290, no. 5, pp. H1899–H1904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. G. P. Collett, A. M. Betts, M. I. Johnson et al., “Peroxisome proliferator-activated receptor α is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma,” Clinical Cancer Research, vol. 6, no. 8, pp. 3241–3248, 2000. View at Google Scholar · View at Scopus
  39. F. Hayashi, H. Tamura, J. Yamada, H. Kasai, and T. Suga, “Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats,” Carcinogenesis, vol. 15, no. 10, pp. 2215–2219, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. R.-S. Meng, Z.-H. Pei, R. Yin et al., “Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-α signaling pathway,” European Journal of Pharmacology, vol. 620, no. 1–3, pp. 63–70, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. J. B. Tennakoon, Y. Shi, J. J. Han et al., “Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch,” Oncogene, vol. 33, no. 45, pp. 5251–5261, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. B. N. Finck, J. J. Lehman, T. C. Leone et al., “The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus,” The Journal of Clinical Investigation, vol. 109, no. 1, pp. 121–130, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. S.-Y. Park, Y.-R. Cho, B. N. Finck et al., “Cardiac-specific overexpression of peroxisome proliferator–activated receptor-α causes insulin resistance in heart and liver,” Diabetes, vol. 54, no. 9, pp. 2514–2524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Wilson, A. Contreras-Ferrat, N. Venegas et al., “Testosterone increases GLUT4-Dependent glucose uptake in cardiomyocytes,” Journal of Cellular Physiology, vol. 228, no. 12, pp. 2399–2407, 2013. View at Publisher · View at Google Scholar · View at Scopus